Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Common Cold
What we know about SARS-CoV-2 immunity so far
SARS-CoV-2, a novel coronavirus that emerged in 2019, is the seventh human coronavirus to be described. Four human coronaviruses circulate seasonally and cause common colds (alphacoronaviruses NL63 and 229E; betacoronaviruses HKU1 and OC43). Two other coronaviruses, SARS-CoV and MERS-CoV, have crossed from animal sources and have not become endemic.
May 25, 2020
NIH offers update on coronavirus outbreak
The outbreak of the novel coronavirus -- dubbed 2019-nCoV -- in the Chinese city of Wuhan has involved hundreds of people and resulted in 18 deaths as of January 23. Global health authorities have scrambled to contain the outbreak and keep it from spreading; one case has already been reported in the U.S., in the state of Washington.
January 23, 2020
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Page 1 of 1
